A.J.P. Yates, R.E.S. Gray, R.C. Percival, K.I. Muncy, J.H. Galloway, M. Couch, R. Vaishnav, J.A. Gallagher, J.N. Beresford, R.G.G. Russell, J.A. Kanis
{"title":"Mechanism of action of stanozolol in the treatment of osteoporosis","authors":"A.J.P. Yates, R.E.S. Gray, R.C. Percival, K.I. Muncy, J.H. Galloway, M. Couch, R. Vaishnav, J.A. Gallagher, J.N. Beresford, R.G.G. Russell, J.A. Kanis","doi":"10.1016/0221-8747(84)90039-0","DOIUrl":"10.1016/0221-8747(84)90039-0","url":null,"abstract":"","PeriodicalId":79235,"journal":{"name":"Metabolic bone disease & related research","volume":"5 4","pages":"Page 207"},"PeriodicalIF":0.0,"publicationDate":"1984-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0221-8747(84)90039-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"53546482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Vitamin A, bone resorption and hyperparathyroidism in uraemia","authors":"T. Cundy, J.A. Kanis, M. Earnshaw, G. Heynen","doi":"10.1016/0221-8747(84)90050-X","DOIUrl":"10.1016/0221-8747(84)90050-X","url":null,"abstract":"","PeriodicalId":79235,"journal":{"name":"Metabolic bone disease & related research","volume":"5 4","pages":"Page 210"},"PeriodicalIF":0.0,"publicationDate":"1984-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0221-8747(84)90050-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"104942417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Measurement of total resorption surface in iliac crest trabecular bone in man","authors":"S. Vedi, J.R. Tighe, J.E. Compston","doi":"10.1016/0221-8747(84)90014-6","DOIUrl":"10.1016/0221-8747(84)90014-6","url":null,"abstract":"<div><p>Total resorption surface has been measured under ordinary light and polarized light in trabecular iliac crest bone from 57 healthy subjects and 40 patients with privational or malabsorption metabolic bone disease. Results obtained with the two methods were similar, although values for total resorption surface measured under polarized light were usually lower than those obtained under ordinary light in both groups of subjects studied. This most likely reflects the greater accuracy in the microscopic identification of resorption surface under polarized light.</p></div>","PeriodicalId":79235,"journal":{"name":"Metabolic bone disease & related research","volume":"5 6","pages":"Pages 275-280"},"PeriodicalIF":0.0,"publicationDate":"1984-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0221-8747(84)90014-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17549898","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
J.N. Beresford , J.A. Gallagher , J.W Poser , R.G.G. Russell
{"title":"Production of osteocalcin by human bone cells in vitro. Effects of 1,25(OH)2D3, 24,25(OH)2D3, parathyroid hormone, and glucocorticoids","authors":"J.N. Beresford , J.A. Gallagher , J.W Poser , R.G.G. Russell","doi":"10.1016/0221-8747(84)90064-X","DOIUrl":"10.1016/0221-8747(84)90064-X","url":null,"abstract":"<div><p>Cells have been cultured from human bone that possess several characteristics of osteoblasts, including the capacity to produce osteocalcin (bone Gla protein). In these cultures the production of osteocalcin is dependent on 1,25(OH)<sub>2</sub>D<sub>3</sub> but is not affected by 24,25(OH)<sub>2</sub>D<sub>3</sub> either alone or in combination with 1,25(OH)<sub>2</sub>D<sub>3</sub>. Two glucocorticoids, prednisolone and deflazacort, reverse the stimulation of osteocalcin synthesis by 1,25(OH)<sub>2</sub>D<sub>3</sub> in a dose-dependent manner (10<sup>−9</sup> − 10<sup>−6</sup><em>M</em>. Parathyroid hormone also inhibits osteocalcin production in a dose-dependent fashion (0.2–5 IU/ml). These results demonstrate that human bone cell cultures may be of considerable value in investigating the hormonal and pharmacologic regulation of the production of osteocalcin and other bone proteins in vitro.</p></div>","PeriodicalId":79235,"journal":{"name":"Metabolic bone disease & related research","volume":"5 5","pages":"Pages 229-234"},"PeriodicalIF":0.0,"publicationDate":"1984-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0221-8747(84)90064-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17394968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Osteoporosis associated with pregnancy and lactation: Bone biopsy and skeletal features in three patients","authors":"H.E. Gruber , D.H. Gutteridge , D.J. Baylink","doi":"10.1016/0221-8747(84)90023-7","DOIUrl":"10.1016/0221-8747(84)90023-7","url":null,"abstract":"<div><p>Case reports of three young patients who developed vertebral fractures and skeletal complications during pregnancy and/or lactation are presented. Radiologic features are described. All three had severe disease with three to nine vertebral fractures at presentation postpartum. In two patients, follow-up for 5–7.8 yr (including further pregnancy in each) revealed no further fractures. In general, serum and urine features were normal, the exceptions being a low serum 25-hydroxyvitamin D level (plus intermittent elevation of serum parathyroid hormone) in one, a tendency to low plasma alkaline phosphatase in another, and in the third (the most severely affected patient) a transient rise in urinary hydroxyproline and plasma alkaline phosphatase during a phase of bone loss following her second and third pregnancies.</p><p>Bone biopsies performed 1 to <span><math><mtext>6-</mtext><mtext>1</mtext><mtext>2</mtext></math></span> yr after parturition showed quantitative bone histologic features and bone formation rates that, as a group, were not significantly different from either normal or postmenopausal osteoporotic subjects. These patients did not have osteomalacia and did not show high turnover osteoporotic features. It is possible that this type of osteoporosis may be somewhat self-limiting, although this hypothesis is subject to great influence by any adaptive lifestyle changes introduced by the patient. The severe fracture history of these patients emphasizes the gravity of their bone disease and stresses the need for further study on the etiology and treatment of this form of osteoporosis.</p></div>","PeriodicalId":79235,"journal":{"name":"Metabolic bone disease & related research","volume":"5 4","pages":"Pages 159-165"},"PeriodicalIF":0.0,"publicationDate":"1984-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0221-8747(84)90023-7","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17791060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Congenitally osteopetrotic (op/op) mice are not cured by transplants of spleen or bone marrow cells from normal littermates","authors":"S.C. Marks Jr., M.F Seifert, J.L. McGuire","doi":"10.1016/0221-8747(84)90027-4","DOIUrl":"https://doi.org/10.1016/0221-8747(84)90027-4","url":null,"abstract":"<div><p>Congenital mammalian osteopetrosis is characterized by a generalized skeletal sclerosis due to reduced bone resorption by osteoclasts. This condition can be cured in several mutant strains of mice and rats by transplantation of spleen or bone marrow cells from normal littermates. The ability of this regimen to cure osteopetrosis in <em>op/op</em> mice was examined in 23 mice treated with spleen or bone marrow cells from normal littermates and followed for up to 80 days. In no instance was there radiographic or histologic evidence of removal of the excessive skeletal mass characteristic of the disease. These data show that spleen or bone marrow cells do not cure osteopetrosis in this mutation. Recent demonstrations that not all children with congenital osteopetrosis are cured by bone marrow transplants from HLA-matched donors suggest that the <em>op/op</em> mouse mutation may be a useful model system in which to develop alternate treatments.</p></div>","PeriodicalId":79235,"journal":{"name":"Metabolic bone disease & related research","volume":"5 4","pages":"Pages 183-186"},"PeriodicalIF":0.0,"publicationDate":"1984-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0221-8747(84)90027-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"92086395","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone","authors":"M. Gunness-Hey , J.M. Hock","doi":"10.1016/0221-8747(84)90026-2","DOIUrl":"10.1016/0221-8747(84)90026-2","url":null,"abstract":"<div><p>Although PTH inhibits bone collagen synthesis acutely, prolonged administration of PTH increases trabecular bone mass. The objectives of this study were to develop a simple method to quantitate the anabolic response of cortical and trabecular bone, to determine if the trabecular bone response is at the expense of cortical bone, and to correlate the bone response with changes in serum calcium or phosphate. Subcutaneous injections of 2 to 16 μg/100 g body weight hPTH(1–34) were given daily to weanling rats for 12 days. The trabecular and cortical bone were manually separated from the distal femur, and calcium, hydroxyproline, and extracted dry weight were measured. Growth and renal function were not impaired. Serum calcium (range: 8.9–9.5 mg%) and serum phosphate (range: 7.7–8.5 mg%) did not differ significantly from control serum calcium, 9.1 mg%, or serum phosphate, 8.1 mg%. A dose-related anabolic response was observed in calcium, hydroxyproline, and dry weight of trabecular bone. At the highest dose of hPTH for 12 days, these values were increased above control by 26%, 33%, and 26%, respectively (<em>P</em> < .01). While cortical bone values increased over 12 days, only the dry weight increase was significant (<em>P</em> < .01). Our method showed an increase in trabecular bone mass after daily subcutaneous injections of hPTH (1–34) at doses that were neither toxic nor hypercalcemic. Although the absolute change of cortical bone mass was greater than that of trabecular bone, it was more variable and not statistically significant. Nevertheless, these results indicate that trabecular bone mass did not increase at the expense of cortical bone.</p></div>","PeriodicalId":79235,"journal":{"name":"Metabolic bone disease & related research","volume":"5 4","pages":"Pages 177-181"},"PeriodicalIF":0.0,"publicationDate":"1984-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0221-8747(84)90026-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17791831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Biliary excretion of vitamin d metabolites following oral and parenteral vitamin D","authors":"M.R. Clements, T.M. Chalmers, D.R. Fraser","doi":"10.1016/0221-8747(84)90047-X","DOIUrl":"https://doi.org/10.1016/0221-8747(84)90047-X","url":null,"abstract":"","PeriodicalId":79235,"journal":{"name":"Metabolic bone disease & related research","volume":"5 4","pages":"Pages 209-210"},"PeriodicalIF":0.0,"publicationDate":"1984-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0221-8747(84)90047-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"92129792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Effects of phosphate on calcium release, lysosomal enzyme activity in the medium, and osteoclast morphometry in cultured fetal rat bones","authors":"J.A. Lorenzo , M.E. Holtrop , L.G. Raisz","doi":"10.1016/0221-8747(84)90028-6","DOIUrl":"10.1016/0221-8747(84)90028-6","url":null,"abstract":"<div><p>The relationship between changes in medium phosphate concentration and three indices of cell-mediated resorption in fetal rat bone cultures—calcium release, the activity of the lysosomal enzyme β-glucuronidase in the medium, and the morphology of osteoclasts—has been investigated. Bones treated with either 1 mM or 4 mM phosphate, with or without parathyroid hormone, were examined. After 2 h of culture we found the predominant effect of changes in medium phosphate to be on non-cell-mediated resorption. However, after 24 h changes in medium phosphate affected both cell-mediated and non-cell-mediated resorptive mechanisms. The 24 h effects of phosphate were not associated with either a change in the activity of β-glucuronidase in the medium or in the area of the ruffled border of osteoclasts, but 4 mM phosphate did prevent parathyroid hormone from increasing the area of the clear zone of osteoclasts. These results imply that changes in medium phosphate alter cell-mediated resorption by affecting mechanisms that are independent of increases in β-glucuronidase activity or changes in the ruffled border of osteoclasts but that may involve effects on the clear zone of osteoclasts.</p></div>","PeriodicalId":79235,"journal":{"name":"Metabolic bone disease & related research","volume":"5 4","pages":"Pages 187-190"},"PeriodicalIF":0.0,"publicationDate":"1984-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0221-8747(84)90028-6","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"17791832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}